Objective To evaluate complications of pregnancy, including thromboembolism, in women with extensive vascular malformations associated with Klippel-Tr enaunay syndrome (KTS).
Introduction
Klippel-Tr enaunay syndrome (KTS) is a congenital disease characterised by two major features: vascular malformations and localised disturbed growth of bone or soft tissue.
1,2 KTS is rare, with an estimated prevalence of 1 in 30 000-100 000 liveborn neonates. The aetiology of KTS is not yet fully understood; however, it is most likely the result of a somatic mosaicism: a postzygotic mutation that only affects a subset of the cells within the body. [2] [3] [4] As somatic mosaic mutations are typically not transmitted to offspring, 4 KTS is generally considered to be a non-hereditary disease.
Vascular malformations are dilated, malformed lymphatic or blood vessels, which arise as the result of erroneous vascular development. Various types may be present in KTS: capillary malformations (CM; port-wine stains), venous malformations (VM), lymphatic malformations (LM), and occasionally small arteriovenous malformations (AVM). The disturbed growth in KTS most often comprises hypertrophy (overgrowth), but hypotrophy is sporadically seen.
Both the disturbed growth and the vascular malformations in KTS generally affect the extremities; however, the vascular malformations often cover an even larger area of the body, and may extend to the trunk and pelvic region, including external and internal genitalia. An example of a typical phenotypic appearance of KTS is shown in Figure 1 .
During pregnancy and labour, women with KTS could therefore be particularly at risk of severe complications, such as venous thromboembolism (VTE), resulting from a low-flow state combined with physiological prothrombotic changes, and postpartum haemorrhage (PPH), resulting from vascular anomalies in the pelvic area. [5] [6] [7] Only a few case reports and case series have been published in the literature, describing severe complications during pregnancy such as paraplegia and uterine prolapse. 8, 9 The exact prevalence of complications in pregnancy is unknown, however. Hence, evidence-based guidelines for preconception counselling and obstetric management of patients with KTS are lacking.
In order to gain more knowledge about the risks of pregnancy and childbirth in women with this rare disease, we investigated the prevalence and nature of complications in a cohort of Dutch women with KTS.
Methods

Study design
We conducted a cross-sectional questionnaire-based study in a national cohort of women with KTS. As this study did not fall under the law of the Dutch 'Basic Legislation Research with Human Subjects', it was exempt from approval by the institutional review board of the Academic Medical Centre in Amsterdam (reference number W15_355 #15.0402). Digital informed consent was obtained from all patients.
Patient selection and inclusion criteria
We included adult women, older than 18 years of age, who were diagnosed with KTS by the definition of Oduber et al. 2 : at least a capillary malformation (CM) or venous malformation (VM), combined with disturbed growth of bone or soft tissue in length or girth. 10 We contacted patients through the Dutch KTS cohort, 10 consisting of patients treated in the Academic Medical Centre (AMC) in 
Questionnaire
For the purpose of this study, a comprehensive questionnaire was developed by a multidisciplinary team of experts (JAMP, Obstetrics and Gynecology; SM, Vascular Medicine; and CMAMH, Plastic, Reconstructive, and Hand Surgery). The survey questions addressed patient demographics, clinical features of KTS, history of VTE, and obstetric history. The survey content was partially derived from several existing questionnaires, which were previously tested and used in other patient populations: the March of Dimes preconception and prenatal family health history questionnaire (http://marchofdimes.com/gyponline), a multi-ethnic general health questionnaire from the HELIUS study, 11 and a thrombosis screening tool (Vascular Medicine, AMC).
The online survey was designed in Google Forms (Google Inc., Menlo park, USA). In order to receive detailed and personalised information from all participants, respondents skip to a specific question on a later page based on their answer to a previous closed-ended question. A flowchart of the structure and content of this questionnaire is shown in Figure 2 . The complete questionnaire is available in Appendix S1. All participants completed the introductory part of the questionnaire, with questions about clinical presentation of KTS, magnetic resonance imaging (MRI) findings, and pregnancy outcomes. Patients who had delivered a liveborn or stillborn infant at least once were questioned about complications during the course of their pregnancies. Complications were categorised into antepartum (during pregnancy), peripartum (around labour), and postpartum (until 6 weeks after labour) complications. Complications of interest were any worsening of KTS symptoms, miscarriage, termination of pregnancy, ectopic pregnancy, preterm delivery, intrauterine fetal death, caesarean section, postpartum haemorrhage, thrombophlebitis, or superficial venous thrombosis (SVT), deep vein thrombosis (DVT), and pulmonary embolism (PE). We directly asked patients if these complications occurred, and patients were given the opportunity to report any additional complications. Whenever a respondent reported a complication during pregnancy or childbirth, we asked for further detailed information about treatment, hospital visits, and admissions, and we cross-checked the patient-reported information with the medical information in the available hospital electronic patient files.
Reference population
In order to explore how our findings related to the general population, we searched for data on pregnancy outcomes and complications within the general population. A broad PubMed search was conducted for reference data of population-based cohort studies and meta-analyses (from the last 15 years) on complications of interest: miscarriage, caesarean section, DVT and PE, and PPH. The PubMed search strategy is presented in Appendix S2. We selected the largest, most recently published population-based cohort study for comparison with the results of the KTS cohort. Dutch populationbased cohorts were selected by preference, and if these were not available we selected European or global population samples.
Data analyses
For data analyses on pregnancy outcome, all pregnancies were taken into account. For data analyses on complications, only pregnancies leading to the delivery of a liveborn or stillborn infant were taken into account. Data on current pregnancies (at time of completion of the questionnaire) were therefore not included in the analyses. As most of the data were categorical, descriptive outcomes were generally expressed as absolute numbers (n) and percentages (%) of the total. The prevalence of complications was calculated in two ways: the number of patients who reported a specific complication divided by the total number of patients, and the number of events divided by the total number of pregnancies.
In order to compare the prevalence of complications in the KTS group and the reference population, a relative risk (RR) was calculated according to the method described by Altman et al. 12 A chi-square test was used to statistically test the difference in proportions (events divided by number of pregnancies) between the KTS group and the reference population. We calculated 95% confidence intervals (95% CIs) of these proportions using the method described by Newcombe.
13 A P value of 0.05 or less was considered to be statistically significant.
Results
Contact information was available for 72 hospital-registered adult women with KTS. A total of 60 women completed the questionnaire and were included in the study; patient demographics are summarised in Table 1 . Fortythree women (72%) became pregnant at least once, and in total 97 pregnancies and 86 deliveries were reported. Four patients were pregnant at the time of completing the questionnaire, and three of these patients were nulliparous.
Seventeen patients (28%) did not conceive. Three of these 17 patients (18%; 5% of the entire cohort) reported that the reason for not conceiving was KTS related. The reported reasons were fear of obstetric complications, a uterus malformation, and negative advice from the treating doctor because of the involvement of the uterus.
Pregnancy outcomes
The 43 patients who conceived reported a total of 97 pregnancies. Twelve pregnancies ended in a miscarriage (n = 8), termination of pregnancy (n = 2), ectopic pregnancy (n = 1), and intrauterine fetal death (n = 1). Forty patients had at least one delivery of a liveborn infant, 31 (77%) of whom delivered more than once. In total, there were 85 deliveries of liveborn infants, including one twin delivery and one delivery of a stillborn infant. Pregnancy outcomes are displayed in Table 2 . Seven patients requested for regional anaesthesia during vaginal delivery or caesarean section; the anaesthesiologist refused to perform regional anaesthesia for three of these patients because ultrasound imaging showed extensive vascular malformations in the proximity of the spine. The four patients who received regional anaesthesia did not report bleeding-related complications.
Aggravated KTS symptoms during pregnancy
Klippel-Tr enaunay syndrome (KTS) symptoms worsened during pregnancy in 17 out of 40 patients (43%). The most commonly reported aggravated symptoms were congestion of the vascular malformation (33%) and pain (28%). Some patients reported the appearance of 'new' vascular malformations (3%), impaired mobility (5%), and eczema-like skin changes of the vascular malformation (2.5%).
Thromboembolic complications
A total of seven patients (18%) experienced a deep venous thromboembolic complication (DVT or PE), representing 8% of the pregnancies (Table 2 ). Five out of 40 patients (13%) reported DVT during pregnancy or in the postpartum period, whereas PE occurred in two patients (5%). DVT occurred in the first (n = 2) or second (n = 3) pregnancy. Pulmonary embolism occurred in the second (n = 1) or third pregnancy (n = 1).
Thirteen patients (32.5%) used prophylactic doses of low molecular weight heparin (LMWH) during pregnancy (n = 1) or in the postpartum period (n = 12). One patient reported using antenatal thromboprophylaxis during the entire pregnancy, and although she did not have a history of VTE, she developed a DVT of the communal and external iliac veins despite these preventative measures. Of the 13 patients using thromboprophylaxis during pregnancy or in the postpartum period, seven patients did not have a history of VTE prior to the pregnancy, and six patients had reported episodes of SVT or DVT prior to the pregnancy. DVT occurred in three of the 13 patients treated with prophylactic doses of LMWH (23%), and pulmonary embolism did not occur. In 27 patients who did not use thromboprophylaxis, two DVTs (7%) and two pulmonary embolisms (7%) were reported.
Twenty-one events of thrombophlebitis were reported by 11 patients (28%). All episodes of thrombophlebitis were managed conservatively with compression stockings and anti-inflammatory heparinoid cream.
Postpartum haemorrhage (PPH)
Severe PPH, defined as the loss of >1000 ml of blood, for which a (prolonged) hospital admission or an additional therapeutic intervention was necessary, occurred in nine of 40 patients (23%), with an average of 10.5 events per 100 deliveries ( Table 2) . Seven patients required blood transfusion (18%) and three underwent a surgical intervention to stop the bleeding (8%). Of the 15 patients who used prophylactic or therapeutic anticoagulants, three patients reported PPH (20%). Of the 25 patients without anticoagulant therapy, six patients reported PPH (24%). As previously mentioned, however, almost all patients only started with prophylactic LMWH therapy after the delivery, in the postpartum period, so we could not adequately investigate whether LMWH is a risk factor for PPH in this study.
Comparison with the reference population
In order to explore how our study findings relate to the general population, our data were compared with reference data from the literature, as presented in Table 3 . AVM, arteriovenous malformation; CM, capillary malformation; LM, lymphatic malformation; VM, venous malformation. *Some patients were unsure about the presence of AVMs (n = 26) and LMs (n = 31), and these data were not taken into account.
Deep vein thrombosis (DVT) was present in 5.8% and PE was present in 2.3% of pregnancies, which are extremely high rates compared with the reference population, with a relative risk of 108.9 (95% CI 46.5-255.0) and 106 (95% CI 27.0-418.1), respectively. The prevalence of these complications differed significantly between the groups (P < 0.0001). The risk of severe PPH in patients with KTS was higher than in the reference population (RR 1.81, 95% CI 0.97-3.37), but we were unable to confirm statistical significance (P = 0.06). In this cohort, the mean percentage of miscarriages (8.2%) was somewhat lower than in population-based cohorts from the literature (15.6%), but there was no statistically significant difference (P = 0.31). 14, 15 The mean percentage of caesarean sections (8.2%) was significantly lower in the KTS cohort, when compared with the reference population (P = 0.049).
Discussion
Main findings
Our data suggest an increased risk of DVT, PE, and severe PPH during the course of pregnancy in women with KTS, when compared with the literature on population-based cohorts of women without KTS. Furthermore, KTS symptoms were aggravated in almost half of patients during pregnancy. Women with KTS should be informed about these risks during preconception counselling.
Strengths and limitations
The strength of the present study is that it includes a relatively large group of patients with a very rare disorder. The largest case series published in the literature so far consisted of four patients. 6 Severe pregnancy complications in *Two episodes of erysipelas, pneumonia, hospital admission for imminent preterm labor, failed induction of labor, severe back pain, severe edema of the feet, vaginal blood loss first trimester.
this patient category have previously been described in case reports and case series, 7, 16, 17 but these findings could have been coincidental considering the small sample sizes. This study, enrolling a large proportion of women with KTS in the Netherlands, provides stronger evidence to confirm the high prevalence of these complications. Therefore, this study may create awareness about the risk of KTS in pregnancy and encourage obstetricians to improve obstetric management of women with KTS accordingly.
This study was limited by the self-reporting of pregnancy outcomes and complications. Even though patients with KTS are generally well aware of their medical history, recall bias and false reporting might have played a role. Because of recall bias, less obvious or minor obstetric complications (i.e. 'mild' PPH or hypertension) could be under-reported. In an attempt to minimalise false reporting, we only included direct questions about obstetric history, presented in lay language, in the survey. Besides this, we added confirmation questions for each reported complication (about the treating doctor, hospital visits, and treatment procedures), which gave us the possibility to cross-check the reported complications with the electronic patient files that were available in our academic hospital. We did not encounter conflicting statements. Unfortunately, obstetric management of the participating patients with KTS took place in many hospitals and birth centres throughout the country, and therefore it was not feasible to request and screen all patient records. We expect that the increasing centralization of KTS care, combined with the use of national prospective registries, will enhance data collection and data accessibility in the near future.
The risk of severe PPH could be related to the location of vascular anomalies in the pelvic region or the use of anticoagulants. With the relatively small number of patients with documented MRI results or anticoagulant use, we could not formally test these hypotheses. The same applies to the evaluation of prior SVT or VTE, and the extension of the VMs, as possible risk factors for VTE. Larger (ideally prospective) studies are necessary to determine the role of these possible risk factors.
Interpretation
The high prevalence of VTE and PPH is in accordance with previously published case reports and case series (Table S1) . 7, 16, 17 Severe complications such as paraplegia and uterine prolapse were reported in case studies, 8, 9 but were not found in our study. In addition, our data are in contradiction with current literature on pregnancy outcomes in patients with KTS. For example, preterm labour was reported more often in the published literature (Table S1) . 6, 18, 19 Caesarean sections were performed in 26 of the 59 KTS pregnancies reported in the literature (44% ;  Table S1 ), whereas in our study this was only 8%. We suspect that only the most complicated pregnancies were published in the literature, in which case 'reporting bias' and 'publication bias' would have led to an overestimation of complications.
In our study, caesarean sections were significantly less frequently performed in the KTS group when compared with the reference population. A possible explanation could be that doctors are less likely to choose a surgical approach in order to avoid bleeding-related complications caused by vascular malformations in the proximity of the uterus.
Both pregnancy and KTS are generally considered risk factors for VTE. [20] [21] [22] Although protocols on thromboprophylaxis differ between hospitals, prophylactic anticoagulant therapy is often considered whenever there are two or more risk factors for VTE present. 23 Based on our data, an estimate of 83 VTEs occur per 1000 KTS pregnancies. In the most recent guideline on antithrombotic therapy during pregnancy, Bates et al. 24 recommend the use of LMWH both antepartum and 6 weeks postpartum for patients with an equally high risk of VTE (70 per 1000 pregnancies), such as patients with a positive family history for VTE and homozygosity for factor V Leiden. Taking these findings into consideration, doctors should consider thromboprophylaxis and the use of compression stockings for patients with KTS during pregnancy and in the postpartum period. In this study, however, we were unfortunately not able to properly investigate the benefits of prophylactic LMWH in pregnant patients with KTS because of the small number of patients and the high risk of selection bias in the LMWHtreated group. Concerning the possibly increased risk of severe PPH in this study cohort, there may be a role for MRI in the preconception phase. Thorough examination of the extensiveness of abdominal, retroperitoneal, and pelvic vascular malformations could possibly aid doctors in determining the risk of bleeding and allow them to adjust obstetric management accordingly (e.g. delivery mode and epidural anaesthesia); however, the value of MRI in the prediction of PPH should be further investigated in future studies.
Conclusion
Our data suggest that women with KTS have a high risk of life-threatening complications such as DVT, pulmonary embolism, and possibly severe PPH, when compared with the general population. We advise obstetricians to inform patients with KTS about these risks during preconception counselling. Furthermore, thromboprophylactic therapy should be considered in patients with KTS during pregnancy and in the postpartum period. The value of MRI of pelvic vascular malformations for predicting the risk of PPH should be further investigated.
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